Skip to content

Absci Corporation ABSI Free cash flow

Free cash flow at other companies

Schrodinger logo
SchrodingerSDGR
-$17.34M-112%
Recursion Pharmaceuticals, Inc. logo
Recursion Pharmaceuticals, Inc.RXRX
-$81.36M+39.2%
AbCellera Biologics Inc. logo
AbCellera Biologics Inc.ABCL
-$37.35M-68.3%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
-$25.94M-142%
ADMA Biologics logo
ADMA BiologicsADMA
$55.71M+329%
Precigen logo
PrecigenPGEN
-$44.09M-160%

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%

Valuation

See full
Market cap$1.57B+43.6%
Enterprise value$1.57B+73.1%
P/S855.5×+628×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Calculated from Absci Corporation’s reported figures.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's free cash flow?
Absci Corporation (ABSI) reported free cash flow of -$26.34M in Q1 2026.
How has Absci Corporation's free cash flow changed year-over-year?
Absci Corporation's free cash flow decreased by 20.5% year-over-year, from -$21.86M to -$26.34M.
What is the long-term trend for Absci Corporation's free cash flow?
Over 4 years (2021 to 2025), Absci Corporation's free cash flow has grown at a -1.2% compound annual growth rate (CAGR), from -$98.65M to -$94.03M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.